CME Exam 3: Real-time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations that Might be Targeted with Existing Drugs or Used as Biomarkers

Posted on April 27, 2019 by Gastroenterology
This entry was posted in News. Bookmark the permalink.